PROM1 and neoplasm: The expression of YKL-40 in tumor xenografts obtained from the intracranial injection of cells dissociated from glioblastoma previously treated with chemotherapy or radiotherapy, and sorted for the stem cell marker CD133 was only detected in the CD133+ tumors (9).